Opioid Use Disorder (OUD) Treatment and Harm Reduction Training Using Augmented Reality (AR) Technology

使用增强现实 (AR) 技术进行阿片类药物使用障碍 (OUD) 治疗和减害培训

• 批准号: 9906749
• 负责人: DOUGLAS NELSON
• 金额: $ 22.11万
• 依托单位: LUMIS CORP.
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-15 至 2020-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9906749
• 关键词: Accident and Emergency department; Administrator; Attitude; Augmented Reality; Basic Life Support; Cardiopulmonary Resuscitation; Caregivers; Cellular Phone; Cessation of life; Clinic; Clinical; Complex; Computer software; Credentialing; Depressed Level of Consciousness; Deterioration; Devices; Diagnosis; Disease; Drug usage; Drug user; Education; Educational Curriculum; Educational Materials; Educational Models; Effectiveness; Emergency Medical Technicians; Engineering; Epidemic; Equipment; Evaluation; Family Caregiver; Family member; Feedback; Focus Groups; Goals; Harm Reduction; Health Personnel; Health Professional; Healthcare; Hospitals; Individual; Injections; Institution; Institutional Review Boards; Interview; Knowledge; Learning; Legal patent; Logistics; Manikins; Medicine; Mission; Modality; Naloxone; National Institute of Drug Abuse; Nursing Schools; Opioid; Outcome; Overdose; Paramedical Personnel; Patients; Peripheral; Pharmaceutical Preparations; Pharmacology; Phase; Physiological; Pre-Post Tests; Process; Professional Organizations; Provider; Recommendation; Reporting; Research Methodology; Resources; School Nursing; Series; Site; Small Business Innovation Research Grant; Specialist; Standardization; Structure; Substance Use Disorder; System; Tablets; Technology; Test Result; Testing; Time; Titrations; Training; Training Programs; Training Support; Treatment outcome; United States; Universities; base; commercialization; cost; design; experience; first responder; improved; improved outcome; insight; iterative design; knowledge base; off-patent; operation; opioid mortality; opioid overdose; opioid use disorder; overdose death; peer; prescription opioid; programs; prototype; research and development; response; simulation; skills; software development; synthetic opioid; treatment services; usability

Over the last decade, death from drug overdose has created an epidemic across the United States. In 2017, there were 70,237 deaths from drug overdose, including 47,600 deaths involving opioids—a 12% increase from previous opioid overdose deaths [1]. While overdoses related to prescription opioids have decreased, synthetic opioids made up over half of all opioid-related overdose deaths and increased over 40% from the prior year [1]. The goal in this proposal is closely aligned with the mission of the National Institute of Drug Abuse (NIDA) to educate clinical providers and lay people towards improving treatment and outcomes for those suffering from substance use disorders (SUDs), specifically in response to a drug overdose. Many barriers have been identified for training providers on SUDs [2, 3]. Simulation-based training has shown promise for training providers about responding to drug overdose during Basic Life Support (BLS) training [4]. However, simulation-based training is resource intensive and can be difficult to implement as current simulator technologies require facilities, staff, and technology support. Overdose education and naloxone distribution (OEND) is associated with improved outcomes for people experiencing opioid overdose as well as decreased drug use by people who participated in OEND programs [5-11]. Increasing access to OEND could expand these positive results. The goal of this Phase I SBIR is to develop and integrate a curriculum for OEND using Lumis’s existing augmented reality (AR) healthcare simulator, the InSight Platform. The InSight Platform incorporates knowledge-based and hands-on training, requires less resources than traditional simulation, and supports broad deployment. The proposed curriculum will include a series of opioid overdose scenarios demonstrating patients in various stages of depressed level of consciousness and physiologic deterioration. These scenarios will allow clinical providers and lay people to train for evaluation, diagnosis, and treatment of an opioid overdose with naloxone. Integrating the proposed curriculum for knowledge-based and hands-on training into the InSight Platform has the potential to rapidly and broadly disseminate standardized OEND curriculum. Mixed methods research will: (1) develop and refine a curriculum for providers and patients through structured interviews with subject matter experts (SMEs), (2) integrate curriculum into Lumis’ software with iterative feedback from SMEs throughout the process, and (3) evaluate feasibility, usability, and initial learning efficacy through focus groups and training sessions with facility administrators, clinical providers, and lay people.

在过去的十年里，药物过量导致的死亡在美国各地造成了流行病。在2017年， 有70，237人死于药物过量，其中47，600人死于阿片类药物，增加了12%。 既往阿片类药物过量死亡[1]。虽然与处方阿片类药物有关的过量用药有所减少， 合成阿片类药物占所有阿片类药物相关过量死亡的一半以上， 去年[1]。本提案的目标与国家药物研究所的使命密切相关。 滥用（NIDA）教育临床提供者和外行人，以改善治疗和结果， 那些患有物质使用障碍（SUD）的人，特别是对药物过量的反应。 已经确定了培训提供者在SUD方面的许多障碍[2，3]。基于模拟的培训表明， 承诺培训提供者在基本生命支持（BLS）培训期间应对药物过量[4]。 然而，基于模拟的培训是资源密集型的，并且可能难以像当前的模拟器那样实现 技术需要设施、人员和技术支持。 过量教育和纳洛酮分布（OEND）与人们的结局改善相关 经历阿片类药物过量以及参与OEND计划的人减少药物使用 [5-11]。增加获得开放式能源数据库的机会可以扩大这些积极成果。 第一阶段SBIR的目标是利用Lumis现有的 增强现实（AR）医疗保健模拟器，InSight平台。InSight平台整合了 基于知识和实践的培训，比传统的模拟需要更少的资源， 广泛部署。拟议的课程将包括一系列阿片类药物过量的情况， 患者在不同阶段的抑郁意识水平和生理恶化。这些场景 将允许临床提供者和非专业人员培训阿片类药物的评估，诊断和治疗 纳洛酮过量将拟议的知识培训和实践培训课程纳入 InSight平台有潜力快速广泛地传播标准化的OEND课程。 混合方法研究将：（1）通过结构化的方法为提供者和患者开发和完善课程 与主题专家（SME）的访谈，（2）将课程整合到Lumis的软件中， 在整个过程中来自SME的反馈，以及（3）评估可行性，可用性和初始学习效果 通过焦点小组和与设施管理员、临床提供者和外行人的培训课程。